CRIS: Gunggung dhuwit awis saben saham curis.com

Lambang korporat lan logo Curis Corp (CRIS)

The cash per share structure helps assess the potential of Curis, Inc. (CRIS) to develop small molecules for cancer treatment. The value of 0.59 reflects this status, considering the anticipation of Phase II leukemia trial results and the risks of regulatory bans due to side effects. Capital deficits and a technological lag in oncology create additional threats for investors.

Dana dhuwit saben saham Curis (CRIS): kanggo periode 04.07.2022 - 20.11.2026

Rincian analitis perusahaan Curis (CRIS)

- nilai pasar lan prakiraan target analis:
- informasi kapitalisasi pasar:
- rincian posisi dhuwit lan arus kas:
Ringkesan analisis perusahaan:CRIS Curis Inc.
Produk mawa merek curis.com

This metric reflects the amount of free liquidity per common share. Investors utilize the cash per share trend to assess the issuer's financial autonomy and protection against market volatility. While an increase in this metric confirms solvency, excess cash may reduce the overall return on equity. For Curis, Inc. (CRIS), this reserve is critical when undergoing rigorous FDA reviews. Patent protection for Hedgehog inhibitors provides the company with a strategic advantage in oncology.

Analisis perusahaan pesaing

Dana dhuwit saben siji saham ONC (BeiGene Corp)|Dhuwit awis saben siji saham HALO (Halozyme Therapeutics, Inc.)|Dhuwit awis saben saham Revolution Medicines, Inc. (RVMD)|Dhuwit awis saben saham AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cekelan dhuwit saben saham|URGN - Dana dhuwit saben saham|Bicara Bio - Dhuwit awis diétung saben siji saham|PSNL: Dhuwit awis saben saham|Dana dhuwit saben siji saham ERAS|Dhuwit awis saben siji saham DCTH|Cekelan dhuwit saben saham Y-mAbs Therapeutics Inc YMAB|Dhuwit awis saben saham AURA|CADL (Candel Therapeutics, Inc.) - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Accuray Inc ARAY|Dana dhuwit diétung saben saham SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Citius Oncology|HURA: Dhuwit awis saben saham|Dhuwit awis saben lembar saham TARA (Protara)|FATE (fatetherapeutics.com) - Dhuwit awis saben saham|Cekelan dhuwit saben saham Aadi Bioscience WHWK|Dhuwit awis saben saham TCRX|CSBR - Cekelan dhuwit saben saham|XBiotech - Dhuwit awis saben siji saham|CEL-SCI Corporation (CVM) - Cekelan dhuwit saben saham|OSTX - Dana dhuwit saben saham|Cekelan dhuwit saben saham Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Dhuwit awis saben siji saham|ANL (Adlai Nortye Ltd) - Dana dhuwit saben saham|Dhuwit awis saben siji saham VERU|Tempest Therapeutics (TPST) - Dana dhuwit diétung saben saham|Dhuwit awis saben saham XLO|Dhuwit awis saben siji saham Renovaro RENB|Dhuwit awis saben saham MURA (Mural Oncology PLC)|KAPA - Dhuwit awis saben siji saham|OnKure Therapeutics - Dhuwit awis saben saham|w2.cytomed.sg - Dhuwit awis diétung saben siji saham|APLM: Dhuwit awis saben saham|Cekelan dhuwit saben saham tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Dhuwit awis saben saham|Dhuwit awis saben saham Genprex Inc.|Dhuwit awis saben saham CLDI|Dhuwit awis saben siji saham Sunshine Biopharma, Inc. SBFM|Dhuwit awis saben saham XBIO (Xenetic Biosciences)|Gunggung dhuwit awis saben saham SLRX|PPBT - Dana dhuwit saben saham|AONC (aoncology.com) - Dana dhuwit saben siji saham|BGNE: Dhuwit awis saben saham|Checkpoint Therapeutics Inc (CKPT) - Dhuwit awis saben saham|ELEV (Elevation Oncology Inc.) - Dhuwit awis saben saham|icadmed.com (ICAD) - Dana dhuwit diétung saben saham|Dhuwit awis saben saham IKNA|NTBL (Notable Labs) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham VIRX (Viracta Therapeutics)|Dana dhuwit diétung saben saham MorphoSys AG (MOR)|NAYA Biosciences Corp - Dhuwit awis saben saham|Cekelan dhuwit saben saham ascentage.com